GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
ANKARA, Turkey, Dec 2, 2025 – (ACN Newswire) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical…
CyberYozh App Expands Its B2B Platform for Scalable Digital Operations and Communications
Intermap Awarded Malaysian Flood Mapping Program; Indonesia ILASPP Phase 2 Evaluation Period Extended